Treatment of chronic orthostatic hypotension with ergotamine.
Authors:
- A V ChobanianACA V Chobanian
- C P TifftCTC P Tifft
- D P FaxonDFD P Faxon
- M A CreagerMCM A Creager
- H SackelHSH Sackel
- 1 March 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 67 (3) , 602-609
Abstract
The acute and chronic effects of ergotamine were examined in four patients with chronic orthostatic hypotension. Chronic oral administration of ergotamine tartrate produced significant increases in standing blood pressure and marked clinical improvement, without appreciable recumbent hypertension. The blood pressure increases were not associated with significant changes in plasma norepinephrine or plasma renin activity. No major toxicity was observed at doses of 2-6 mg/day over treatment periods of 3-18 months. Hemodynamic studies on the effects of i.v. ergotamine tartrate (0.25-0.50 mg) revealed that the ergotamine-induced increase in blood pressure in the supine position was associated with an increase in total peripheral resistance (from 1616 +/- 165 to 2574 +/- 583 U) without a change in cardiac output. During 45-60 degrees upright tilt, ergotamine increased both total peripheral resistance (1801 +/- 296 to 3262 +/- 1107 U) and cardiac output (2.42 +/- 0.46 to 3.34 +/- 0.54 l/min). Forearm plethysmographic studies revealed decreased forearm blood flow and venous volume and increased vascular resistance with ergotamine. The orthostatic hypotensives had more platelet alpha-receptors (390 +/- 31 receptors/cell) than the control subjects (234 +/- 17 receptors/cell). The increased receptor level was associated with abnormally low circulating levels of norepinephrine and increased pressor responsiveness to infused norepinephrine in three of the four patients. Chronic ergotamine therapy appeared to reduce platelet alpha-receptor number to normal. The results indicate that ergotamine is of value in certain patients with chronic orthostatic hypotension and that the blood pressure effects are related to vasoconstriction in both arterial and venous beds.Keywords
This publication has 32 references indexed in Scilit:
- Increased Numbers of Beta Receptors in Orthostatic Hypotension Due to Autonomic DysfunctionNew England Journal of Medicine, 1981
- Human platelet α2-adrenergic receptors: Labeling with 3H-yohimbine, a selective antagonist ligandLife Sciences, 1981
- Atrial Tachypacing in the Treatment of a Patient with Primary Orthostatic HypotensionNew England Journal of Medicine, 1980
- Mineralocorticoid-Induced Hypertension in Patients with Orthostatic HypotensionNew England Journal of Medicine, 1979
- Alpha-adrenergic receptor subtypes: Quantitative assessment by ligand bindingLife Sciences, 1979
- Ergonovine maleate provocative test for coronary arterial spasmThe American Journal of Cardiology, 1978
- A sensitive radioenzymatic assay for norepinephrine in tissues and plasmaLife Sciences, 1975
- Effect of Ergotamine and Ergometrine on Forearm Venous Compliance in ManBMJ, 1970
- Ergot poisoningPostgraduate Medical Journal, 1966
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949